Researchers at the Mayo Clinic‘s tissue engineering and biomaterials laboratory have developed a 3D-printed, porous scaffold for the delayed delivery of recombinant-human bone morphogenetic protein 2, rhBMP-2, to facilitate bone regeneration in patients undergoing ACL reconstruction.
The team’s work developing the scaffold and comparing different delivery methods for rhBMP-2 was published this week in Tissue Engineering.
Get the full story at our sister site, Drug Delivery Business News.